Docetaxel: overview of an active drug for breast cancer.

Abstract

Docetaxel and paclitaxel differ in their precise molecular targets and pharmacokinetics. Docetaxel is more avidly taken up by tumor cell lines than paclitaxel, and its efflux is slower. Comparative cytotoxicity data suggest greater potency. These factors may help explain the clinical differences that have been observed between the taxanes in patients with… (More)

2 Figures and Tables

Topics

  • Presentations referencing similar topics